Title:

Letter from P. H. Makela to Joshua Lederberg

Creator:

Ma?kela?, P. Helena

Recipient:

Lederberg, Joshua

Date:

13 January 1965

Location:

Box: 12. Folder: 72

Rights:

Reproduced with permission of P. H. Makela.

Genre:

Letters (correspondence)

Format:

Text

Extent:

1 pages

Language:

English

Legacy ID:

BBAKUR

NLM ID:

101584906X7244

Profiles Collection:

The Joshua Lederberg Papers

Shareable Link:

https://profiles.nlm.nih.gov/101584906X7244

Annotation:

Author: Joshua Lederberg. Date Written: January 8, 2003. Node: Dr Helena Makela was a postdoc in my lab at Stanford; She received the 2002 award of the Prince Mahidol Foundation for her service to global Public Health; Dr. P. Helena Makela, M.D., Ph.D., research Professor Emerita, National Public Health Institute of Finland. Her most important work is related to Hemophilus Influenza type B - Hib conjugated vaccine to prevent invasive disease in young children. The Hib conjugated vaccine has been used in the national infant immunzation program in the U.S.A., Canada and several European countries in each of them nearly eliminating meningitis, and is now being extended to children in developing countries. The annual number of deaths preventable through global inclusion of Hib vaccine in infant immunization programs has been estimated at approximately 300,000. Dr.Makela has also developed a vaccine for pneumonia using the Pneumococcas pneumonia potentially reducing 1.1 - 1.4 million deaths annually. jl 1/8/03

Lederberg Grouping:

CD. Correspondence D.